170 related articles for article (PubMed ID: 33932781)
21. Halogen-substituted anthranilic acid derivatives provide a novel chemical platform for androgen receptor antagonists.
Roell D; Rösler TW; Hessenkemper W; Kraft F; Hauschild M; Bartsch S; Abraham TE; Houtsmuller AB; Matusch R; van Royen ME; Baniahmad A
J Steroid Biochem Mol Biol; 2019 Apr; 188():59-70. PubMed ID: 30615932
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel androgen receptor antagonists using structure- and ligand-based methods.
Li H; Ren X; Leblanc E; Frewin K; Rennie PS; Cherkasov A
J Chem Inf Model; 2013 Jan; 53(1):123-30. PubMed ID: 23278403
[TBL] [Abstract][Full Text] [Related]
23. Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor Inhibitors.
Helsen C; Nguyen TT; Lee XY; Eerlings R; Louros N; Schymkowitz J; Rousseau F; Claessens F; Voet A
Mol Cancer Ther; 2022 Dec; 21(12):1823-1834. PubMed ID: 36218067
[TBL] [Abstract][Full Text] [Related]
24. High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.
Hua Y; Shun TY; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2014 Sep; 12(7):395-418. PubMed ID: 25181412
[TBL] [Abstract][Full Text] [Related]
25. High-Content Screening Campaign to Identify Compounds That Inhibit or Disrupt Androgen Receptor-Transcriptional Intermediary Factor 2 Protein-Protein Interactions for the Treatment of Prostate Cancer.
Fancher AT; Hua Y; Camarco DP; Close DA; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2018; 16(6):297-319. PubMed ID: 30109944
[TBL] [Abstract][Full Text] [Related]
26. Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth.
Kawahara T; Ide H; Kashiwagi E; El-Shishtawy KA; Li Y; Reis LO; Zheng Y; Miyamoto H
Urol Oncol; 2016 Oct; 34(10):432.e15-23. PubMed ID: 27330033
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity.
Wang LG; Liu XM; Kreis W; Budman DR
Biochem Biophys Res Commun; 1999 May; 259(1):21-8. PubMed ID: 10334909
[TBL] [Abstract][Full Text] [Related]
28. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p'-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat.
Wolf C; Lambright C; Mann P; Price M; Cooper RL; Ostby J; Gray LE
Toxicol Ind Health; 1999; 15(1-2):94-118. PubMed ID: 10188194
[TBL] [Abstract][Full Text] [Related]
29. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
Wang LG; Liu XM; Kreis W; Budman DR
Biochem Pharmacol; 1998 May; 55(9):1427-33. PubMed ID: 10076535
[TBL] [Abstract][Full Text] [Related]
30. Molecular Dynamics Simulations Revealed the Regulation of Ligands to the Interactions between Androgen Receptor and Its Coactivator.
Liu N; Zhou W; Guo Y; Wang J; Fu W; Sun H; Li D; Duan M; Hou T
J Chem Inf Model; 2018 Aug; 58(8):1652-1661. PubMed ID: 29993249
[TBL] [Abstract][Full Text] [Related]
31. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
Andrieu T; Bertolini R; Nichols SE; Setoud R; Frey FJ; Baker ME; Frey BM
Biochem Pharmacol; 2011 Dec; 82(11):1651-62. PubMed ID: 21907706
[TBL] [Abstract][Full Text] [Related]
32. Structural Dynamics of Agonist and Antagonist Binding to the Androgen Receptor.
Azhagiya Singam ER; Tachachartvanich P; La Merrill MA; Smith MT; Durkin KA
J Phys Chem B; 2019 Sep; 123(36):7657-7666. PubMed ID: 31431014
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptor antagonists for prostate cancer therapy.
Helsen C; Van den Broeck T; Voet A; Prekovic S; Van Poppel H; Joniau S; Claessens F
Endocr Relat Cancer; 2014 Aug; 21(4):T105-18. PubMed ID: 24639562
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanism of R-bicalutamide switching from androgen receptor antagonist to agonist induced by amino acid mutations using molecular dynamics simulations and free energy calculation.
Liu H; Han R; Li J; Liu H; Zheng L
J Comput Aided Mol Des; 2016 Dec; 30(12):1189-1200. PubMed ID: 27848066
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a Novel Androgen Receptor Antagonist Manifesting Evidence to Disrupt the Dimerization of the Ligand-Binding Domain via Attenuating the Hydrogen-Bonding Network Between the Two Monomers.
Fu W; Zhang M; Liao J; Tang Q; Lei Y; Gong Z; Shan L; Duan M; Chai X; Pang J; Tang C; Wang X; Xu X; Li D; Sheng R; Hou T
J Med Chem; 2021 Dec; 64(23):17221-17238. PubMed ID: 34809430
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of second-generation tropanol-based androgen receptor modulators.
Sundén H; Holland MC; Poutiainen PK; Jääskeläinen T; Pulkkinen JT; Palvimo JJ; Olsson R
J Med Chem; 2015 Feb; 58(3):1569-74. PubMed ID: 25646649
[TBL] [Abstract][Full Text] [Related]
37. Classifying chemical mode of action using gene networks and machine learning: a case study with the herbicide linuron.
Ornostay A; Cowie AM; Hindle M; Baker CJ; Martyniuk CJ
Comp Biochem Physiol Part D Genomics Proteomics; 2013 Dec; 8(4):263-74. PubMed ID: 24013142
[TBL] [Abstract][Full Text] [Related]
38. Preclinical pharmacology of FL442, a novel nonsteroidal androgen receptor modulator.
Poutiainen PK; Huhtala T; Jääskeläinen T; Petsalo A; Küblbeck J; Kaikkonen S; Palvimo JJ; Raunio H; Närvänen A; Peräkylä M; Juvonen RO; Honkakoski P; Laatikainen R; Pulkkinen JT
Mol Cell Endocrinol; 2014 Apr; 387(1-2):8-18. PubMed ID: 24565895
[TBL] [Abstract][Full Text] [Related]
39. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
Hara T; Miyazaki J; Araki H; Yamaoka M; Kanzaki N; Kusaka M; Miyamoto M
Cancer Res; 2003 Jan; 63(1):149-53. PubMed ID: 12517791
[TBL] [Abstract][Full Text] [Related]
40. Detection of ligand-selective interactions of the human androgen receptor by SELDI-MS-TOF.
Linke T; Scholten M; Baniahmad A
Methods Mol Biol; 2011; 776():225-51. PubMed ID: 21796530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]